Member Info for Owl11

I don't believe anyone does feel sure it is this Monday, it's just the build up of anticipation that we are getting closer with each passing day.

How bizarre, I'm with you on this one Axe.

I sincerely hope they are genuine branded Smarties and not Aldi specials. :)

£5.73 with RNS (Obviously)

623
https://twitter.com/kickoffsocial/status/1484168218621194246?s=20

Nope, can't see him either.

Jobs advertised as initially home based, you can draw your own conclusions from that.

https://twitter.com/MARYau_MCU_PH/status/1481741557690781696?s=20

Agreed, great movie.

https://www.einnews.com/pr_news/560263916/aerosol-delivery-devices-market-is-growing-at-a-cagr-of-4-9-from-2020-to-2027-latest-research-report

A2P2 to A2P3 was supposed to be a seamless progression, if its correct that recruitment hasn't started then it does seem out of line with the original protocol. Perhaps a change in thinking?

https://studyfinder.umn.edu/studies/24820

I've seen the remarks now several times re management clocking up the air miles, I don't have access to Reddit unfortunately so not privy to this information. Can it be usefully be summarised on here without compromising a contact?

Absolutely, the timing is significant as they know P3 data will be released soon, I find it hard to believe they would risk losing face by drawing attention to the deal should they not be entirely confident the agreement will come to fruition, just my thoughts.

Thanks gggg21, I'm biased of course but them tweets really do sound enthusiastic, like they are expecting this contract to be huge, let's see.

It matters not if they are selling to bank profits or change of strategy, it will make no difference to our P3 results which are paramount. Its a minor irritation which is insignificant in comparison to this week's positive news.

Agreed that everything points towards J.V, although i suspect the team is smart enough to insert a break clause should other options become available and of interest.

72 x faster data analytics according to their website.

2021 was truly an epic year for Synairgen as we hit important milestones, grew the team and made preparations for the future.

Thank you to our partners for your continued support. Together we are ready to hit the ground running in 2022.

Taj Pharmaceuticals
@taj_pharma
World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — #remdesivir, #hydroxychloroquine, #lopinavir, & #interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19).
??info@tajpharma.com/+91 8448 444 095